297 related articles for article (PubMed ID: 19153272)
21. Early atherosclerosis aggravates renal microvascular loss and fibrosis in swine renal artery stenosis.
Sun D; Eirin A; Ebrahimi B; Textor SC; Lerman A; Lerman LO
J Am Soc Hypertens; 2016 Apr; 10(4):325-35. PubMed ID: 26879682
[TBL] [Abstract][Full Text] [Related]
22. Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis.
Eirin A; Zhu XY; Li Z; Ebrahimi B; Zhang X; Tang H; Korsmo MJ; Chade AR; Grande JP; Ward CJ; Simari RD; Lerman A; Textor SC; Lerman LO
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1006-13. PubMed ID: 23430615
[TBL] [Abstract][Full Text] [Related]
23. Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy.
Chen XJ; Zhang X; Jiang K; Krier JD; Zhu X; Conley S; Lerman A; Lerman LO
J Cell Physiol; 2020 Dec; 235(12):9806-9818. PubMed ID: 32430932
[TBL] [Abstract][Full Text] [Related]
24. Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular disease.
Zhang L; Zhu XY; Zhao Y; Eirin A; Liu L; Ferguson CM; Tang H; Lerman A; Lerman LO
Basic Res Cardiol; 2020 Jan; 115(2):16. PubMed ID: 31938859
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin abates development of renal fibrosis in experimental renovascular disease.
Chade AR; Zhu XY; Grande JP; Krier JD; Lerman A; Lerman LO
J Hypertens; 2008 Aug; 26(8):1651-60. PubMed ID: 18622245
[TBL] [Abstract][Full Text] [Related]
26. Early superoxide scavenging accelerates renal microvascular rarefaction and damage in the stenotic kidney.
Kelsen S; He X; Chade AR
Am J Physiol Renal Physiol; 2012 Aug; 303(4):F576-83. PubMed ID: 22622460
[TBL] [Abstract][Full Text] [Related]
27. Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular Disease.
Engel JE; Williams ML; Williams E; Azar C; Taylor EB; Bidwell GL; Chade AR
Am J Nephrol; 2020; 51(11):891-902. PubMed ID: 33130676
[TBL] [Abstract][Full Text] [Related]
28. Renoprotective effects of hepatocyte growth factor in the stenotic kidney.
Stewart N; Chade AR
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F625-33. PubMed ID: 23269649
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.
Chade AR; Rodriguez-Porcel M; Grande JP; Zhu X; Sica V; Napoli C; Sawamura T; Textor SC; Lerman A; Lerman LO
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1295-301. PubMed ID: 12750121
[TBL] [Abstract][Full Text] [Related]
30. Experimental Renovascular Disease Induces Endothelial Cell Mitochondrial Damage and Impairs Endothelium-Dependent Relaxation of Renal Artery Segments.
Nargesi AA; Zhu XY; Saadiq IM; Jordan KL; Lerman A; Lerman LO; Eirin A
Am J Hypertens; 2020 Aug; 33(8):765-774. PubMed ID: 32179886
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease.
Kelsen S; Hall JE; Chade AR
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F218-25. PubMed ID: 21478482
[TBL] [Abstract][Full Text] [Related]
32. Low-Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation.
Zhang X; Krier JD; Amador Carrascal C; Greenleaf JF; Ebrahimi B; Hedayat AF; Textor SC; Lerman A; Lerman LO
J Am Soc Nephrol; 2016 Dec; 27(12):3715-3724. PubMed ID: 27297945
[TBL] [Abstract][Full Text] [Related]
33. Targeted VEGF (Vascular Endothelial Growth Factor) Therapy Induces Long-Term Renal Recovery in Chronic Kidney Disease via Macrophage Polarization.
Engel JE; Williams E; Williams ML; Bidwell GL; Chade AR
Hypertension; 2019 Nov; 74(5):1113-1123. PubMed ID: 31542966
[TBL] [Abstract][Full Text] [Related]
34. Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular disease.
Chade AR; Stewart NJ; Peavy PR
Kidney Int; 2014 Apr; 85(4):833-44. PubMed ID: 24352153
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve the Renal Microvasculature in Metabolic Renovascular Disease in Swine.
Eirin A; Zhu XY; Jonnada S; Lerman A; van Wijnen AJ; Lerman LO
Cell Transplant; 2018 Jul; 27(7):1080-1095. PubMed ID: 29954220
[TBL] [Abstract][Full Text] [Related]
36. Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia.
Chade AR; Krier JD; Textor SC; Lerman A; Lerman LO
J Am Soc Nephrol; 2006 Dec; 17(12):3394-403. PubMed ID: 17082239
[TBL] [Abstract][Full Text] [Related]
37. Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease.
Eirin A; Zhu XY; Ferguson CM; Riester SM; van Wijnen AJ; Lerman A; Lerman LO
Stem Cell Res Ther; 2015 Jan; 6(1):7. PubMed ID: 25599803
[TBL] [Abstract][Full Text] [Related]
38. Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome.
Yuan F; Hedayat AF; Ferguson CM; Lerman A; Lerman LO; Eirin A
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H669-H680. PubMed ID: 29196345
[TBL] [Abstract][Full Text] [Related]
39. Coexisting renal artery stenosis and metabolic syndrome magnifies mitochondrial damage, aggravating poststenotic kidney injury in pigs.
Nargesi AA; Zhang L; Tang H; Jordan KL; Saadiq IM; Textor SC; Lerman LO; Eirin A
J Hypertens; 2019 Oct; 37(10):2061-2073. PubMed ID: 31465309
[TBL] [Abstract][Full Text] [Related]
40. Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension.
Lerman LO; Taler SJ; Textor SC; Sheedy PF; Stanson AW; Romero JC
Kidney Int; 1996 Mar; 49(3):846-54. PubMed ID: 8648929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
